Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...
News Medical on MSN6h
Developing and refining muscle atrophy models for drug discoveryWith the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, ...
UK Biobank's proteomics study will measure 5,400 proteins in 600,000 samples, tracking changes over mid-to-late life. By ...
A new era, where AI is at the centre of the drug discovery process is emerging, says Charlotte Deane, a professor of ...
The global biotechnology industry market size is projected to expand from USD 483.0 billion in 2024 to USD 546.0 billion by ...
Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...
Bioanalysis is also used to monitor therapeutic responses by evaluating drug levels, biomarkers, and physiological changes ...
This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback